Vivoryon Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Vivoryon Therapeutics has a total shareholder equity of €14.0M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €17.0M and €3.0M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €15.27m |
| Equity | €13.98m |
| Total liabilities | €3.01m |
| Total assets | €16.99m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VVYA's short term assets (€16.0M) exceed its short term liabilities (€1.7M).
Long Term Liabilities: VVYA's short term assets (€16.0M) exceed its long term liabilities (€1.3M).
Debt to Equity History and Analysis
Debt Level: VVYA is debt free.
Reducing Debt: VVYA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VVYA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VVYA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19% each year